» Articles » PMID: 18424249

Development of in Vivo MuCT Evaluation of Neovascularisation in Tissue Engineered Bone Constructs

Overview
Journal Bone
Date 2008 Apr 22
PMID 18424249
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Due to an increasing aging population the need for innovative approaches to aid skeletal repair and reconstruction is a significant socio-economic increasing problem. The emerging discipline of tissue engineering has sort to augment the growth and repair of bone loss particularly in areas of trauma, degeneration and revision surgery. However, the initiation and development of a fully functional vascular network are critical for bioengineered bone to repair large osseous defects, whether the material is osteosynthetic (poly (d,l)-lactic acid, PLA) or natural bone allograft. Quantification and three-dimensional visualization of new vessel networks remain a problem in bone tissue engineering constructs. A novel technique utilising a radio-opaque dye and micro-computed tomography (muCT) has been developed and applied to study angiogenesis in an impaction bone graft model. Tissue-engineered constructs combining human bone marrow stromal cells (HBMSC) with natural allograft and synthetic grafts (PLA) were impacted and implanted into the subcutis of MF-1 nu/nu mice for a period of 28 days. Microfil consisting of radio-opaque polymer was perfused through the mice and scanned using a Bench Top CT system for micro-computed tomography. Analysis of three-dimensional muCT reconstructions demonstrated an increase in vessel volume and vessel number in the impacted scaffolds/HBMC compared to scaffolds alone. Vessel volume: allograft/HBMSC=0.57 mm(3)+/-0.19; allograft=0.04 mm(3)+/-0.04; PLA/HBMSC=1.19 mm(3)+/-0.31; and PLA=0.12 mm(3)+/-0.01. Penetrating vessel number: allograft/HBMSC=22.33+/-3.21; allograft=3.67+/-1.153; PLA/HBMSC=32.67+/-8.33; and PLA=7.67+/-3.06. Type 1 collagen and von Willebrand factor immunohistochemistry in scaffold/HBMSC constructs indicated the osteogenic cell phenotype, and new blood vessel formation respectively. Contrast-enhanced 3D reconstructions facilitated the visualization and quantification of neovascularisation. This novel technique has been used to demonstrate neovascularisation in impacted tissue engineered constructs providing a facile approach with wide experimental application.

Citing Articles

Scaffold vascularization method using an adipose-derived stem cell (ASC)-seeded scaffold prefabricated with a flow-through pedicle.

Debski T, Kurzyk A, Ostrowska B, Wysocki J, Jaroszewicz J, Swieszkowski W Stem Cell Res Ther. 2020; 11(1):34.

PMID: 31973733 PMC: 6979360. DOI: 10.1186/s13287-019-1535-z.


In Situ Endoscopic Analysis of Vascular Supply and Regenerated Alveolar Bone in -TCP Grafted and Ungrafted Postextraction Sites before Implant Placement: A Prospective Case Control Study.

Beltran V, Lazzarini M, Figueroa R, Sousa V, Engelke W Biomed Res Int. 2019; 2019:2797210.

PMID: 31781606 PMC: 6875396. DOI: 10.1155/2019/2797210.


Phenotyping the Microvasculature in Critical-Sized Calvarial Defects via Multimodal Optical Imaging.

Mendez A, Rindone A, Batra N, Abbasnia P, Senarathna J, Gil S Tissue Eng Part C Methods. 2018; 24(7):430-440.

PMID: 29901424 PMC: 6056256. DOI: 10.1089/ten.TEC.2018.0090.


Three dimensional printed polylactic acid-hydroxyapatite composite scaffolds for prefabricating vascularized tissue engineered bone: An in vivo bioreactor model.

Zhang H, Mao X, Zhao D, Jiang W, Du Z, Li Q Sci Rep. 2017; 7(1):15255.

PMID: 29127293 PMC: 5681514. DOI: 10.1038/s41598-017-14923-7.


Growth differentiation factor 15 promotes blood vessel growth by stimulating cell cycle progression in repair of critical-sized calvarial defect.

Wang S, Li M, Zhang W, Hua H, Wang N, Zhao J Sci Rep. 2017; 7(1):9027.

PMID: 28831101 PMC: 5567281. DOI: 10.1038/s41598-017-09210-4.